Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure
about
The roles of CD147 and/or cyclophilin A in kidney diseasesRepressing CD147 is a novel therapeutic strategy for malignant melanoma.High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse.Prognosis of sepsis induced by cecal ligation and puncture in mice improved by anti-Clonorchis Sinensis cyclopholin a antibodiesThe proteogenomic path towards biomarker discoveryMethyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice.The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusionCyclophilin A: a key player for human diseaseCyclophilin-CD147 interactions: a new target for anti-inflammatory therapeutics.Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation.The role of proteomics in understanding biological mechanisms of sepsis.CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.Proteome changes in mesenteric lymph induced by sepsis.Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease.Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
P2860
Q28083416-CF0E9056-EA64-4EAF-9FBF-D411344AEA4DQ33649045-EB615B3E-CE09-4D7E-9487-6B6B77FFE8DEQ35917505-2FAA9B8C-D075-403B-85B6-13CB6DD727CEQ36114901-82CE4918-7DD2-4EA1-895C-2B4296B37D6AQ36952173-83D11DE2-04D3-43A7-A2CB-B1BA5C382B65Q37018467-58B8223B-6928-44C0-840F-BF1FED70ECF6Q37259282-4C879DBB-5CF4-4981-86DE-FD614F5EE9F1Q37577487-EFE22269-4991-452B-89C9-FEB6D3883A4AQ37719732-8784BC47-15B9-4409-A8AC-37D28D878899Q37743010-0C661D55-11F0-45CE-9E97-B0107D9144B9Q38171431-A9F5EEA6-4BD7-4F8D-B1BC-A8ED54E6C465Q38253491-6FB795CC-2386-4636-8385-544B9CB62046Q41731285-526AE24C-EB1E-4A10-9EE8-180C621A3F97Q50117655-5B24C95C-7518-4D47-950E-0E25B747B82BQ51066069-DE570975-D07C-4EBC-A0C7-8B0429989F82
P2860
Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Liver proteomics for therapeut ...... is-induced acute renal failure
@ast
Liver proteomics for therapeut ...... is-induced acute renal failure
@en
type
label
Liver proteomics for therapeut ...... is-induced acute renal failure
@ast
Liver proteomics for therapeut ...... is-induced acute renal failure
@en
prefLabel
Liver proteomics for therapeut ...... is-induced acute renal failure
@ast
Liver proteomics for therapeut ...... is-induced acute renal failure
@en
P2093
P2860
P1476
Liver proteomics for therapeut ...... is-induced acute renal failure
@en
P2093
Angel Aponte
Asada Leelahavanichkul
James W Dear
Peter S T Yuen
Robert A Star
Stephanie L Constant
P2860
P304
P356
10.1097/01.CCM.0000281858.44387.A2
P407
P577
2007-10-01T00:00:00Z